Literature DB >> 29336553

Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics.

Xiang Zhai1, Thomas D Meek1.   

Abstract

Cruzain, an important drug target for Chagas disease, is a member of clan CA of the cysteine proteases. Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors. To this end, we have determined pH-rate profiles for substrates and affinity agents and solvent kinetic isotope effects in pre-steady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC, and Cbz-Arg-Ala-AMC. The pH-rate profile of kcat/ Km for Cbz-Arg-Arg-AMC indicated p K1 = 6.6 (unprotonated) and p K2 ∼ 9.6 (protonated) groups were required for catalysis. The temperature dependence of the p K = 6.2-6.6 group exhibited a Δ Hion value of 8.4 kcal/mol, typical of histidine. The pH-rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a p Ka of 9.8. Normal solvent kinetic isotope effects were observed for both D2O kcat (1.6-2.1) and D2O kcat/ Km (1.1-1.4) for all three substrates. Pre-steady-state kinetics revealed exponential bursts of AMC production for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC. The overall solvent isotope effect on kcat can be attributed to the solvent isotope effect on the deacylation step. Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine have neutral charges in the free enzyme. The generation of the active thiolate of the catalytic cysteine is likely preceded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad into the proximity to effect proton transfer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29336553     DOI: 10.1021/acs.biochem.7b01250

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.

Authors:  Bala C Chenna; Linfeng Li; Drake M Mellott; Xiang Zhai; Jair L Siqueira-Neto; Claudia Calvet Alvarez; Jean A Bernatchez; Emily Desormeaux; Elizabeth Alvarez Hernandez; Jana Gomez; James H McKerrow; Jorge Cruz-Reyes; Thomas D Meek
Journal:  J Med Chem       Date:  2020-03-17       Impact factor: 7.446

2.  Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents.

Authors:  Jiyun Zhu; Linfeng Li; Aleksandra Drelich; Bala C Chenna; Drake M Mellott; Zane W Taylor; Vivian Tat; Christopher Z Garcia; Ardala Katzfuss; Chien-Te K Tseng; Thomas D Meek
Journal:  Front Chem       Date:  2022-07-04       Impact factor: 5.545

Review 3.  Inverse Solvent Isotope Effects in Enzyme-Catalyzed Reactions.

Authors:  Patrick L Fernandez; Andrew S Murkin
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

4.  Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.

Authors:  Kemel Arafet; Natalia Serrano-Aparicio; Alessio Lodola; Adrian J Mulholland; Florenci V González; Katarzyna Świderek; Vicent Moliner
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

5.  Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/MM computational methods.

Authors:  Katarzyna Świderek; Vicent Moliner
Journal:  Chem Sci       Date:  2020-06-25       Impact factor: 9.825

6.  Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2.

Authors:  A V Nemukhin; B L Grigorenko; S V Lushchekina; S D Varfolomeev
Journal:  Russ Chem Bull       Date:  2022-01-15       Impact factor: 1.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.